Markets Leede Jones Gable starts CareRx at buy; PT $6.50 (Canadian) Leede Jones Gable initiated coverage of CareRx (TSX:CRRX) with a “buy” rating and one-year price target of $6.50 (Canadian). The stock was quoted at $3.75, up 26 cents, near mid-day on Dec. 15. CareRx, formerly known as... December 15, 2020